Journal list Promote Sponsor
verified SJR 0,361 · Q3 • database Scopus / SJR & Web of Science indexed
Future Virology
United Kingdom · Taylor and Francis Ltd.
workspace_premium Q3 — Virology lock Subscription

Future Virology

Future Virology is a journal indexed in SJR in Virology with an H index of 48. It has a price of 2395 €. It has an SJR impact factor of 0,361 and it has a best quartile of Q3. It has an SJR impact factor of 0,361.

ISSN: 1746-0794
Publisher: Taylor and Francis Ltd.
Category: Virology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,361 Q3
H-index 48
Acceptance rate pie_chart
33%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
2.395 € Subscription
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,361

H-index

48

Docs (year)

46

Docs 3y

279

Total refs

2480

Cites 3y

367

Citable 3y

256

Cites/Doc 2y

1.39

Ref/Doc

53.91

Immediate OA

2395 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Characteristics of viral IL-10 gene in Epstein-Barr virus infection in children in China

View more

Virus and noncoding RNAs: stars in the host-virus interaction game

View more

EBV glycoproteins: where are we now?

View more

Current and future targets of antiviral therapy in the hepatitis C virus life cycle

View more

Could inhibiting IL-8 enhance HBV IFN-a treatment?

View more

Could boosting the oligoadenylate synthetase-like pathway bring a new era of antiviral therapy?

View more

Corneal latency and transmission of herpes simplex virus-1

View more

Controversies in 21st century virology

View more

Conformational analysis of hepatitis B virus surface antigen mutations among HIV-positive patients diagnosed with occult hepatitis B virus

View more

Comparison of renal changes with lopinavir/ritonavir plus raltegravir or tenofovir/emtricitabine in the PROGRESS study

View more

Community-associated methicillin-resistantStaphylococcus aureusand HIV

View more

Combating Japanese encephalitis: Vero-cell derived inactivated vaccines and the situation in Japan

View more
SHOW MORE ARTICLES

Characterization and risk of blood-borne virus transmission in organ transplantation: what are the priorities?

View more

A closed-handed affair: positive-strand RNA virus polymerases

View more

CD8 T-cell response to respiratory syncytial virus infection

View more

Cardiovascular risk prediction in patients with HIV infection

View more

Candidate medical countermeasures targeting Ebola virus cell entry

View more

Can the HPV vaccine prevent more than cervical cancer? An epidemiologic perspective

View more

Can the ever-promising target HIV reverse transcriptase-associated RNase H become a success story for drug development?

View more

Can an influenza A-based delivery system overcome current challenges associated with miRNA technology?

View more

Arboviruses: variations on an ancient theme

View more

Apoptosis and autophagy as a turning point in viral-host interactions: the case of human norovirus and its surrogates

View more

Antiviral and inflammatory crosstalk in the control of RNA virus infection

View more

Albumin-interferon-a in the treatment of chronic hepatitis C

View more

FAQs